Price transparency at the point of prescribing with real-time prescription benefits
American Journal of Health-System Pharmacy · 2024
DOI: 10.1093/ajhp/zxae108 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2024. Verfasst von Austin Fitts und 2 weiteren Autor:innen. Beteiligte Einrichtung: HealthIT, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Price Transparency, Prescription Fees, Health Expenditures, Prescription Drugs. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Real-time prescription benefits (RTPB) shows prescribers patient-, medication-, and pharmacy-specific information on medication pricing, prior authorization requirements, and lower-cost alternatives. RTPB is intended to improve patient satisfaction and prescription fill rates by decreasing out-of-pocket costs for prescriptions. Therefore, we evaluated how RTPB affects prescribing patterns by examining acceptance and subsequent fill rates for RTPB alternative suggestions.
Methods
RTPB was implemented in February 2022 using external vendor interfaces. Prescribing data from March 2022 to March 2023 were analyzed. RTPB displayed alerts for medications requiring prior authorization or when alternative medications would result in cost savings. Patients were included if their prescription received an RTPB response and they had a subsequent encounter with pharmacy fill data. Primary outcomes were alert acceptance rates and prescription fill rates across RTPB alert groups, with a secondary outcome of monthly copay savings for accepted alerts.
Results
RTPB requests received a response for 88% of prescriptions, with price estimates provided for 77.9% of them. Lower-cost alternatives accounted for 67.2% of alerts, while prior authorization requirements represented 15% of alerts. Prescribers selected a lower-cost alternative 32% of the time. For those with an RTPB alert, patients filled prescriptions 68% of the time when an alternative was chosen, compared to 59% of the time when the original prescription was retained (odds ratio, 1.5; 95% confidence interval, 1.5-1.6; P < 0.001). Patients saved an average of $27.77 per month on copay costs when alternatives were selected.
Conclusion
Implementation of RTPB was found to result in significant improvements in prescription fill rates and decrease patient copay costs, despite low alert acceptance rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HealthIT, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Zitieren
APA
Fitts, A., Teare, A. J., & Nelson, S. D. (2024). Price transparency at the point of prescribing with real-time prescription benefits. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae108
Vancouver
Fitts A, Teare AJ, Nelson SD. Price transparency at the point of prescribing with real-time prescription benefits. American Journal of Health-System Pharmacy. 2024. doi:10.1093/ajhp/zxae108
BibTeX
@article{Fitts2024,
author = {Fitts, Austin and Teare, Andrew J and Nelson, Scott D},
title = {Price transparency at the point of prescribing with real-time prescription benefits},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
doi = {10.1093/ajhp/zxae108}
}
EUVIMED